ARCHIVES

Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum

This article is from The Cancer Letter archive.

Vol. 19 No. 02 | January 8, 1993

Download PDF Visit The Full Archive

Related Articles

New Grant Programs In Radiology, Clinical Correlates, Ok’d

June 21, 1991

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

January 31, 2003

NIH Offers Curriculum Supplements For K-12

November 5, 1999

Expert Review Of ImClone Protocol Concludes C225 Approval Unlikely.

February 15, 2002

Organ Systems Meeting Canceled

November 19, 1982

In Brief: GAO Probe Of Cancer Control Program Nears End; Renewal Bill Mark Up Not Before Oct. 22

October 12, 1979